Cargando…

Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common pathological type of non-Hodgkin lymphoma (NHL). It is strongly correlated to the host immunity and infection status. Aim: This study tested the hypothesis that hepatitis B virus (HBV) infection is also associated with DLBCL. Metho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanchun, Wang, Huijie, Pan, Shaokun, Hu, Tao, Shen, Jiabin, Zheng, Hui, Xie, Suhong, Xie, Youhua, Lu, Renquan, Guo, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950586/ https://www.ncbi.nlm.nih.gov/pubmed/29760795 http://dx.doi.org/10.7150/jca.24384

Ejemplares similares

Identification of a Torque Teno Mini Virus (TTMV) in Hodgkin’s Lymphoma Patients
por: Pan, Shaokun, et al.
Publicado: (2018)

Chronic hepatitis B virus infection is associated with a poorer prognosis in diffuse large B-cell lymphoma: a meta-analysis and systemic review
por: Rong, Xingyu, et al.
Publicado: (2019)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma
por: Wang, Feng, et al.
Publicado: (2008)

Characterization and engineering of broadly reactive monoclonal antibody against hepatitis B virus X protein that blocks its interaction with DDB1
por: Tao, Shuai, et al.
Publicado: (2019)

Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G
por: Chen, Ruidong, et al.
Publicado: (2017)

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin
por: Deng, Lijuan, et al.
Publicado: (2015)

Concurrent and reactivation of hepatitis B virus infection in diffuse large B-cell lymphoma: risk factors and survival outcome
por: Guo, Ya-fei, et al.
Publicado: (2018)

Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance
por: Shen, Zhongliang, et al.
Publicado: (2017)

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy
por: XIE, WANZHUO, et al.
Publicado: (2013)

PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection
por: Liu, Zhihe, et al.
Publicado: (2017)

Clinical Analysis and Prognostic Significance of Hepatitis B Virus Infections with Diffuse Large B-Cell Lymphoma
por: Kang, Xindan, et al.
Publicado: (2020)

Identification of an individualized RNA binding protein‐based prognostic signature for diffuse large B‐cell lymphoma
por: Xie, Yongzhi, et al.
Publicado: (2021)

Establishment of a detection assay for DNA endonuclease activity and its application in the screening and prognosis of malignant lymphoma
por: Lu, Renquan, et al.
Publicado: (2018)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era
por: Nuersulitan, Reyizha, et al.
Publicado: (2022)

MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection
por: Liu, Zhihe, et al.
Publicado: (2017)

Apatinib enhances chemosensitivity of ABT‐199 in diffuse large B‐cell lymphoma
por: Shi, Yuanfei, et al.
Publicado: (2022)

A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell Lymphoma
por: Sato, Kentaro, et al.
Publicado: (2022)

Genomic and transcriptomic characterization reveals B‐cell hyperactivation and immune evasion in hepatitis B virus‐associated diffuse large B‐cell lymphoma
por: Qin, Wei, et al.
Publicado: (2023)

An Unusual Presentation of Primary Hepatic Diffuse Large B-cell Lymphoma of the Liver
por: Dhingra, Rohit, et al.
Publicado: (2018)

Primary Hepatic Diffuse Large B-cell Lymphoma Mimicking Intrahepatic Cholangiocarcinoma
por: Kawakami, Hiroshi, et al.
Publicado: (2018)

Epigenomic evolution in diffuse large B-cell lymphomas
por: Pan, Heng, et al.
Publicado: (2015)

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
por: Chen, Kai-Lin, et al.
Publicado: (2015)

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
por: Park, Jeayeon, et al.
Publicado: (2023)

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012)

Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)

Cutaneous diffuse large B‐cell lymphoma
por: Duarte Ribeiro, Filipa, et al.
Publicado: (2017)

Genomics of diffuse large B cell lymphoma
por: Koh, Youngil
Publicado: (2021)

Diffuse Large B-Cell Lymphoma of the Cecum
por: Azad, Farhan, et al.
Publicado: (2023)

Primary testicular diffuse large B-cell lymphoma: Case series
por: Wang, Qi, et al.
Publicado: (2020)

The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma
por: Fang, Xia, et al.
Publicado: (2017)

Establishment of a typing model for diffuse large B-cell lymphoma based on B-cell receptor repertoire sequencing
por: Jiang, Wenhua, et al.
Publicado: (2021)

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients
por: Xu, Yi, et al.
Publicado: (2023)

Influence of Statins on the Survival Outcomes of Patients with Diffuse Large B Cell Lymphoma: A Systematic Review and Meta-Analysis
por: Li, Yanbing, et al.
Publicado: (2022)

Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Gupta, Varsha, et al.
Publicado: (2022)

New agents and regimens for diffuse large B cell lymphoma
por: Wang, Liang, et al.
Publicado: (2020)

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
por: Shen, Rong, et al.
Publicado: (2023)

Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China
por: Chen, Dao-guang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e39vqe0ff2t1det3337f1v1vm9